Veracyte reported $1.05B in Equity Capital and Reserves for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Agenus AGEN:US USD -20385000 23.8M
Agilent A:US USD 5.29B 198M
Anika Therapeutics ANIK:US USD 284.94M 1.22M
Arrowhead Research ARWR:US USD 398.52M 55.41M
Bruker BRKR:US USD 937M 33.5M
Exact Sciences EXAS:US USD 3.11B 100.71M
Heron Therapeutics HRTX:US USD 22.45M 44.19M
Illumina ILMN:US USD 6.73B 3.71B
Immunogen IMGN:US USD 178.01M 71.82M
Intrexon XON:US USD 142.53M 86.88M
Karyopharm Therapeutics KPTI:US USD -140280000 23.94M
Laboratory Of America LH:US USD 10.09B 308.5M
Ligand Pharmaceuticals LGND:US USD 816.3M 13.93M
Myriad Genetics MYGN:US USD 916.6M 30.8M
Rigel Pharmaceuticals RIGL:US USD 19.83M 23.51M
Sangamo Biosciences SGMO:US USD 309.15M 9.13M
Siemens SIE:GR EUR 48.9B 3.17B
Sonic Healthcare SHL:AU AUD 7.27B 219.28M
Thermo Fisher Scientific TMO:US USD 43.61B 1.32B
Veracyte VCYT:US USD 1.05B 15.97M
Waters WAT:US USD 385.24M 6.89M